# Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)

Study · id `cardio:ct-nct07552194` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07552194](<https://clinicaltrials.gov/study/NCT07552194>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07552194

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 272 participants.

## Technical summary

Registry record NCT07552194. Randomized; double masking; primary purpose treatment. Start 2026-06-02 (anticipated); primary completion 2027-12-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 272 participants (planned count; ClinicalTrials.gov record NCT07552194, source copy `cardio:ctgov-nct07552194-2026-04-27`, retrieved 2026-10-26)
- Planned start: 2026-06-02 (anticipated) (ClinicalTrials.gov record NCT07552194, source copy `cardio:ctgov-nct07552194-2026-04-27`, retrieved 2026-10-26)
- Primary completion: 2027-12-20 (anticipated) (ClinicalTrials.gov record NCT07552194, source copy `cardio:ctgov-nct07552194-2026-04-27`, retrieved 2026-10-26)
- Completion: 2028-02-20 (anticipated) (ClinicalTrials.gov record NCT07552194, source copy `cardio:ctgov-nct07552194-2026-04-27`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07552194-2026-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)
- Acronym: ROBUST
- Condition: Coronary Artery Disease (CAD)
- Condition: Coronary Bifurcation Lesion
- Condition: Coronary Stenting
- Condition: Drug Eluting Balloon
- Intervention (Device): Balloon Angioplasty with or without drug administration
- Lead sponsor: Avtandil M. Babunashvili
- Lead sponsor class: OTHER
- Collaborator: I.M. Sechenov First Moscow State Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: I.M. Sechenov First Moscow State Medical University (`cardio:org-i-m-sechenov-first-moscow-state-medical-university`)

## Provenance

Content hash: cf0795b8fdf99dcf83e9af01db2aab69be41b34127a08241e25597694de1c8be
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
